A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.

In what is believed to be the first large-scale study to quantify the development of breast cancer according to the degree of glandular tissue versus fat, researchers headed by UC San Francisco evaluated risk factors in more than 200,000 women.

E-cigarettes – thought by some to be responsible for a decline in youth cigarette smoking – are actually attracting a new population of adolescents who might not otherwise have smoked tobacco products, according to a new UC San Francisco study.

New research led by researchers from UC San Francisco and Stanford University has found that successful cancer immunotherapy appears to depend on whether the treatment can trigger a system-wide immune response, rather than just a local response within the tumor itself.

To honor and build on a lifetime of giving and charitable service by the late Helen Diller, the Helen Diller Foundation has granted $500 million to UC San Francisco, a university to which Helen was both generous and devoted. The gift will be the largest ...

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the UCSF Helen Diller Family Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation (CTI) have renewed an agreement to identify and develop biologic compounds against both known and novel targets, including the immune system, in diseases such as cancer, cardiovascular and metabolic diseases. The collaboration allows UCSF and ...

Karla Kerlikowske, MD, and team recently published a paper in the Journal of the National Cancer Institute that examined the role of common risk factors in the development of ER-positive and ER-negative breast cancers. The study sheds new light on how a woman's age, weight, ...

A better cure for cancer – and other illnesses – could already be in existence, hidden right under our noses.

For the second consecutive year, UC San Francisco is co-hosting the Precision Medicine World Conference (PMWC), which is being held in January 2017. Precision Medicine World ConferenceThe annual forum brings together experts to speak about the latest findings across health care, data and biotechnology sectors. When: Jan.